Immune Repertoire Sequencing Market Insights Video
According to Cognitive Market Research, the global Immune Repertoire Sequencing market size will be USD 172.5 million in 2024. It will expand at a compound annual growth rate (CAGR) of 7.90% from 2024 to 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 69.00 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.1% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 51.75 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 39.68 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.9% from 2024 to 2031.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 8.63 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 3.45 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.6% from 2024 to 2031.
Biotechnology and Pharmaceutical Companies represent the dominant end-user segment. These companies are heavily involved in the development of novel therapies, including immunotherapies and vaccines, where immune profiling plays a critical role
